1 |
Van Groeneandael JHLM, Markusse HM, Dijkmans BAC, et al., The effect of ranitidine on NSAID-related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis or osteoarthritis. Clin Rheumatol 1996; 15: 450-456.
DOI
ScienceOn
|
2 |
Taha AS, Hudson N, Hawkey CJ, et al., Famotidine for the prevention of gastric a duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med 1996; 334: 1435-1439.
DOI
ScienceOn
|
3 |
Singh G, Triadafilopoulus G. Epidemiology of NSAID induced GI complications. J Rheumatol 1999; 26: 18-24.
|
4 |
Yun HR, Corzillius M, Kim SY, Bae SC. Korean costeffectiveness analysis of NSAIDs, NSAIDs with cotreatments to prevent gastrointestinal toxicity, and COX-2 specific inhibitors in the treatment of rheumatoid arthritis. Korean J Med 2001; 60: 574-588.
|
5 |
Yeomans ND, Tulassay Z, Juhasz L et al., A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. Acid Suppression Trial: Ranitidine vs. Omeprazole for NSAID associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998; 338: 719-726.
DOI
ScienceOn
|
6 |
Hawkey CJ, Karrasch JA, Szczepanski L et al., Omeprazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs. Omeprazole vs. Misoprostol for NSAID-Induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998; 33: 727-734.
|
7 |
Lanza FL, Peace K, Gustitus L et al., A blinded endoscopic comparative study of misoprostol vs. sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration. Am J Gastroenterol 1988; 83: 143-146.
|
8 |
Agrawal NM, Roth S, Graham DY et al., Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. a randomized, controlled trial. Ann Intern Med 1991; 115: 195-200.
DOI
ScienceOn
|
9 |
McCarthy DM. Sucralfate. N Engl J Med 1991; 325: 1017-1025.
DOI
ScienceOn
|
10 |
Garcia Rodriguez LA, Hernandez-Diaz S. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal antiinflammatory drugs. Epidemiology 2001; 12: 570-576.
DOI
ScienceOn
|
11 |
Hernandez-Diaz S, Rodriguez LA. Association between nonsteroidal antiinflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000; 160: 2093-2099.
DOI
ScienceOn
|
12 |
de Abajo FJ, Garcia Rodriguez LA. Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric coated formulations. BMC Clin Pharmacol 2001; 1: 1.
|
13 |
Rostom A, Dube C, Wells G et al., Prevention of NSAIDinduced gastroduodenal ulcers. Cochrane Database Syst Rev 2002; 4: CD002296.
|
14 |
Leontiadis GI, Sreedharan A, Dorward S et al., Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess 2007; 11: 1-164.
|
15 |
Kim JW. NSAID-induced gastroenteropathy. Korean J Gastroenterol 2008; 52: 134-141.
|
16 |
Aalykke C, Lauritsen K. Epidemiology of NSAID-related gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol 2001; 15: 705-722.
DOI
|
17 |
Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999; 340: 1888-1899.
DOI
ScienceOn
|
18 |
Aalykke C, Lauritsen K. Epidemiology of NSAID-related gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol 2001; 15: 705-722.
DOI
|
19 |
Lanza FL et al., Guidelines for prevention of NSAIDrelated ulcer complications. Am J Gastroenterol. 2009; 104(3): 728-38.
DOI
ScienceOn
|
20 |
Macro Lazzaroni and Gabriele Bianchi Porro. Management of NSAID-Induced Gastrointestinal Toxicity. Drugs 2009; 69(1): 51-69.
DOI
ScienceOn
|
21 |
Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999; 340: 1888-1899.
DOI
ScienceOn
|
22 |
Shorr RI, Ray WA, Daugherty JR, Griffin MR. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med 1993;153:1665-1670.
DOI
ScienceOn
|
23 |
Chou R, Helfand M, Peterson K, Dana T, Roberts C. Comparative effectiveness and safety of analgesics for osteoarthritis. Comparative effectiveness review no. 4. Rockville, Md.: Agency for Healthcare Research and Quality; September 2006.
|
24 |
Gabriel SE, Jaakkimainen L, Bomaberdier C. Risk for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs: a meta analysis. Ann Intern Med 1991; 115: 787-96.
DOI
ScienceOn
|
25 |
Silverstein FE, Graham DY, Senior JR, et al., Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal antiinflammatory drugs. A randomized, double-blind, placebocontrolled trial. Ann Intern Med 1995; 123: 241-249.
DOI
ScienceOn
|
26 |
Bijlsma JW. Treatment of NSAID-induced gastrointestinal lesions with cimetidine: an international multicenter collaborative study. Aliment Pharmacol Ther 1988; 2: 85-95
|